Minor
AR882 in Gout Patients (AR882-301)
Trial completed
Also in this update: Final enrollment: 866 participants (planned 750)
Arthrosi TherapeuticsPhase 3 NCT06846515 Registry history of NCT06846515 on ClinicalTrials.gov (opens the registry)
Updated